About Dinutuximab Beta
Class: | Monoclonal antibody
Use: | Treatment of high-risk neuroblastoma in pediatric patients, typically used in combination with other therapies
Adult dose: | Not applicable; primarily used in pediatric patients
Pediatric dose: | 17.5 mg/m² administered as an intravenous infusion over 10 hours, given once daily for 5 consecutive days every 28 days for up to 5 cycles
Side effects: | Fever, hypotension, pain, allergic reactions, infusion-related reactions, and myelosuppression
Contrain
Drug Class
Monoclonal antibody
Uses & Indications
Treatment of high-risk neuroblastoma in pediatric patients, typically used in combination with other therapies
Storage Requirements
Store in a refrigerator at 2°C to 8°C (36°F to 46°F); do not freeze; protect from light
Manufacturer & Packaging
Manufacturer: EUSA Pharma (Netherlands) B.V., Netherlands
Package Size
4.5ml Vial
Price & Supplier
Price in UAE: AED 42504.00
Dosage Information
Adult Dose
Not applicable; primarily used in pediatric patients
Pediatric Dose
17.5 mg/m² administered as an intravenous infusion over 10 hours, given once daily for 5 consecutive days every 28 days for up to 5 cycles
Side Effects
Fever, hypotension, pain, allergic reactions, infusion-related reactions, and myelosuppression
Contraindications & Precautions
Hypersensitivity to dinutuximab beta or any component of the formulation; severe allergic reactions
Important Warnings
Risk of severe infusion-related reactions; monitor patients closely during infusion; may cause neurotoxicity; ensure adequate hydration and premedication to reduce infusion reactions
Medical Disclaimer
This information is for educational purposes only and should not replace professional medical advice.
Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication.
The information presented here is specific to medicines available in UAE pharmacies and is regularly updated
to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.